Biochem/physiol Actions
Cell permeable: no
Reversible: no
Product does not compete with ATP.
Primary TargetDAG lipase
Target IC50: 4 nM against DAG lipase activity in canine platelets
General description
Selective inhibitor of DAG lipase activity in canine platelets (IC50 = 4 nM) and in a variety of mammalian cells. Also inhibits glucose- and carbachol-induced insulin release from intact islets. An inhibitor of Angiotensin II (Cat. No. 05-23-0101) and ATP-induced synthesis of 6-keto-prostaglandin F1α.
Selective inhibitor of DAG lipase activity in canine platelets (IC50 = 4 nM) and in a variety of mammalian cells. Also inhibits glucose- and carbachol-induced insulin release from intact islets. An inhibitor of Angiotensin II and ATP-induced synthesis of 6-keto-prostaglandin F1α.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Shinoda, J., et al. 1997. Arterioscler. Thromb. Vasc. Biol. 17, 295.Shinoda, J., et al. 1997. Eur. J. Endocrinol. 136, 207.Konrad, R.J., et al. 1994. Biochemistry 33, 13284.Mason-Garcia, M., et al. 1992. Am. J. Physiol.262, C1197.Balsinde, J., et al. 1991. J. Biol. Chem.266, 15638.
Packaging
10 mg in Plastic ampoule
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria: